Compare Enveric Biosciences Inc (ENVB) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs iShares Global Clean Energy ETF — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while iShares Global Clean Energy ETF trades at $18.42. The key difference: iShares Global Clean Energy ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | ICLN | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $23.75 |
52-Week Low | $1.28 | $13.41 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
ICLN is trading at $18.65, down 2.2% today amid bearish technical signals with 14 sell indicators versus 4 buy signals. The ETF has shown strong performance in 2026 with a 29% YTD return, outperforming the S&P 500, driven by AI momentum and high global energy prices. Recent news highlights clean energy sector strength with multiple ETF comparisons showing ICLN's competitive positioning against traditional energy and infrastructure funds.
The outlook remains cautiously optimistic as clean energy benefits from structural tailwinds including data center demand and global energy security concerns. Key risks include regulatory uncertainty from stalled US permits threatening $121 billion in investment and geopolitical tensions affecting Chinese solar manufacturers. Analyst sentiment appears mixed with some viewing the recent pullback as a buying opportunity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
